Healthcare101

 The global conversation around plastic pollution has intensified in recent years—and rightly so. Microplastics, the tiny particles resulting from the breakdown of plastic materials, have become one of the most pressing environmental challenges of our time. As concerns rise across industries, the microplastic analysis market is emerging as a critical enabler of environmental monitoring, regulatory compliance, and public health protection. According to recent projections, the global microplastic analysis market is expected to grow significantly— from USD 266.9 million in 2025 to USD 383.1 million by 2030 , reflecting a CAGR of 7.5% . This steady expansion highlights the growing urgency for accurate detection, quantification, and characterization of microplastics across various ecosystems. Download PDF Brochure Why Is the Microplastic Analysis Market Growing? 1. Rising Environmental Awareness Governments, industries, and consumers are becoming more conscious of the long-t...

  Market Overview The preimplantation genetic testing (PGT) market is experiencing substantial growth, driven by the increasing demand for genetic screening during in vitro fertilization (IVF) procedures. PGT involves analyzing embryos for genetic abnormalities before implantation, allowing clinicians to select healthy embryos for transfer, thereby increasing the chances of successful pregnancy and reducing the risk of genetic disorders in offspring. The global preimplantation genetic testing market is projected to grow from USD 690.2 million in 2025 to USD 1,135.0 million by 2030, at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2030. This growth is attributed to several factors, including: Increasing Awareness of Genetic Disorders: Growing awareness among couples about the risk of transmitting genetic disorders to their children is driving the demand for PGT. Advancements in Technology: Technological advancements in PGT techniques, su...

  Market Overview The blood gas analyzer market is estimated at USD 2.70 billion in 2025 and is projected to reach USD 3.38 billion by 2030, growing at a CAGR of 4.6% during the forecast period. Blood gas analyzers are in-vitro diagnostic devices used to measure the partial pressures of oxygen (PO2) and carbon dioxide (PCO2), pH, and other parameters in blood samples. These measurements are crucial for assessing a patient's respiratory and metabolic status, particularly in critical care settings. The results obtained from blood gas analysis help clinicians diagnose and manage various conditions, including respiratory failure, acid-base imbalances, and electrolyte disorders. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963 Market Size and Forecast The global blood gas analyzer market is experiencing steady growth. The market size was valued at USD 2.70 billion in 2025 and is expected to reach USD 3.38 billion by 2030, representing...

  Understanding the Role of Screening in Mental Well-Being Mental health is a cornerstone of overall wellness, yet millions across the world continue to live with undiagnosed or untreated conditions such as anxiety, depression, post-traumatic stress disorder (PTSD), and bipolar disorder. Mental health screening serves as a vital tool for early detection, timely intervention, and improved outcomes. Through structured assessments conducted in hospitals, schools, workplaces, and increasingly through digital platforms, these screenings empower individuals to seek care before mental health challenges become severe. Global Market Growth: Rising Awareness and Demand The global mental health screening market is expanding at a robust pace. Valued at US$0.8 billion in 2022 , the market grew to US$0.9 billion in 2023 and is projected to advance at a compound annual growth rate (CAGR) of 12.2% from 2023 to 2029—reaching US$1.8 billion by the end of the forecast period. This grow...

  The global hearing aids market , valued at US$9.74 billion in 2024 , stood at US$10.35 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030 , culminating in a forecasted valuation of US$14.42 billion by the end of the period . The market’s growth trajectory is underpinned by a rising geriatric population, increasing prevalence of hearing loss, and rapid advancements in digital and wireless sound technologies. As hearing aids evolve from basic amplification devices into smart, connected systems, their role in enhancing quality of life and communication continues to expand across global and regional markets. To know about the assumptions considered for the study download the pdf brochure Rising Hearing Loss Cases Fuel Global Demand Hearing impairment has emerged as a major global health concern, affecting more than 430 million people worldwide, according to the World Health Organization (WHO). Factors such as prolonged exposure to noise p...

  Market Overview The global vascular access devices market is experiencing steady growth, driven by factors such as the increasing prevalence of chronic diseases, the rising geriatric population, and technological advancements in vascular access procedures. In 2023, the market was valued at US$5.60 billion. Demonstrating consistent expansion, the market reached US$5.99 billion in 2024. The global vascular access devices market, valued at US$5.60 billion in 2023, stood at US$5.99 billion in 2024 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$9.05 billion by the end of the period.  Download PDF Brochure: Market Growth and Projections The market is projected to maintain a robust growth rate over the next several years. From 2024 to 2030, the global vascular access devices market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.1%. This growth rate reflects the increasing demand for...

  Market Overview The global prefilled syringe market , valued at US$6.40 billion in 2023, stood at US$7.10 billion in 2024 and is projected to advance at a resilient CAGR of 10.8% from 2024 to 2030, culminating in a forecasted valuation of US$13.14 billion by the end of the period. Prefilled syringes (PFS) are single-dose medication delivery systems that offer several advantages over traditional vials and ampoules. These advantages include improved accuracy, reduced risk of contamination, ease of use, and minimized drug waste. As a result, prefilled syringes have gained significant traction in the pharmaceutical and biopharmaceutical industries, driving market growth. Download PDF Brochure: Market Dynamics Several factors are contributing to the robust growth of the global prefilled syringe market: Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases such as diabetes, rheumatoid arthritis, and cardiovascular diseases is d...

  Market Overview The global injection pen market is a significant segment within the broader drug delivery systems industry. Injection pens are prefilled or reusable devices designed for self-administration of medication, offering convenience, accuracy, and ease of use compared to traditional syringes. These devices are particularly popular among patients with chronic conditions requiring regular injections, such as diabetes, rheumatoid arthritis, and growth hormone deficiencies. Download PDF Brochure Market Size and Historical Growth In 2023, the global injection pen market was valued at US$43.8 billion. This substantial valuation underscores the widespread adoption of injection pens as a preferred method for drug delivery. By 2025, the market had grown to US$47.0 billion, reflecting a steady increase in demand driven by factors such as the rising prevalence of chronic diseases, technological advancements in pen design, and a growing preference for self-administration of...